Cargando…
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
To establish novel and effective treatment combinations for chronic myelomonocytic leukemia (CMML) preclinically, we hypothesized that supplementation of CMML cells with the human oncogene Meningioma 1 (MN1) promotes expansion and serial transplantability in mice, while maintaining the functional de...
Autores principales: | Kloos, Arnold, Mintzas, Konstantinos, Winckler, Lina, Gabdoulline, Razif, Alwie, Yasmine, Jyotsana, Nidhi, Kattre, Nadine, Schottmann, Renate, Scherr, Michaela, Gupta, Charu, Adams, Felix F., Schwarzer, Adrian, Heckl, Dirk, Schambach, Axel, Imren, Suzan, Humphries, R. Keith, Ganser, Arnold, Thol, Felicitas, Heuser, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116758/ https://www.ncbi.nlm.nih.gov/pubmed/32576961 http://dx.doi.org/10.1038/s41375-020-0929-3 |
Ejemplares similares
-
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2021) -
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2020) -
Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020) -
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
por: Chaturvedi, Anuhar, et al.
Publicado: (2020) -
P1278: MEASURABLE RESIDUAL DISEASE ASSESSMENT IN THE PROSPECTIVE HAPLOMUD STUDY
por: Arnhardt, Isabell, et al.
Publicado: (2023)